首页 > 最新文献

Patologiya krovoobrashcheniya i kardiokhirurgiya最新文献

英文 中文
Diepoxy-treated bovine jugular vein conduit for pulmonary artery replacement 二氧氧处理的牛颈静脉导管用于肺动脉置换术
Q4 Medicine Pub Date : 2022-12-29 DOI: 10.21688/1681-3472-2022-4-19-32
N. R. Nichay, I. Zhuravleva, Y. Kulyabin, I. Zykov, E. V. Boyarkin, O. Malakhova, E. V. Kuznetsova, T. Timchenko, Y. Rusakova, I. Murashov, A. Dokuchaeva, A. Bogachev-Prokophiev
Objective: To evaluate the performance and short-term capacity of the diepoxy-treated bovine jugular vein conduit in large animals during 6-month follow-up.Methods: Thirteen diepoxy-treated bovine jugular vein conduits were implanted into the pulmonary artery of young mini-pigs. During the follow-up, graft function was tested using transesophageal echocardiography. The animals were withdrawn at 6 months, and the explanted conduits were assessed histologically.Results: All the conduits were successfully implanted without any surgical complications. All the animals survived throughout the follow-up. By the end of the follow-up period, the pressure gradient increased on five animals’ conduits including one case of mismatch between the conduit and the native pulmonary artery, two cases of distal stenosis, and two case of endocarditis. No significant increase in valve regurgitation or conduit thrombosis was observed during the follow-up. In conduits without dysfunction, the structure of the walls and leaflets was intact. A thin fibrous tissue covered the conduit inner wall with complete surface endothelialization. Neither signs of degeneration or calcification nor inflammatory cells were found in the conduit wall or leaflets. Neointima proliferation without calcium deposits was observed in two distally stenosed conduits. Inflammatory cells consisting of multinucleated macrophages, lymphocytes, and histiocytes were found in the adventitia. There were no inflammatory cells in the media or intima, and the leaflets showed no changes.Conclusion: Diepoxy-treated bovine jugular vein demonstrated acceptable performance, good endothelialization, and low tendency to thrombosis and calcium accumulation in the wall and leaflets.Received 31 October 2022. Revised 25 November 2022. Accepted 28 November 2022.Funding: The study was supported by Russian Science Foundation (grant No. 22-25-20102).Conflict of interest: The authors declare no conflict of interest.Contribution of the authorsConception and study design: N.R. Nichay, I.Yu. Zhuravleva, A.V. Bogachev-ProkophievData collection and analysis: N.R. Nichay, Yu.Yu. Kulyabin, I.S. Zykov, E.V. Boyarkin, O.Yu. Malakhova, E.V. Kuznetsova, T.P. Timchenko, Ya.L. Rusakova, I.S. Murashov, A.A. DokuchaevaStatistical analysis: N.R. Nichay, I.Yu. ZhuravlevaDrafting the article: N.R. Nichay, I.Yu. Zhuravleva, Yu.Yu. Kulyabin, I.S. Zykov, E.V. Boyarkin, O.Yu. Malakhova, T.P. Timchenko, Ya.L. Rusakova, I.S. Murashov, A.A. DokuchaevaCritical revision of the article: N.R. Nichay, I.Yu. Zhuravleva, Yu.Yu. Kulyabin, A.A. Dokuchaeva, A.V. Bogachev-ProkophievFinal approval of the version to be published: N.R. Nichay, I.Yu. Zhuravleva, Yu.Yu. Kulyabin, I.S. Zykov, E.V. Boyarkin, O.Yu. Malakhova, E.V. Kuznetsova, T.P. Timchenko, Ya.L. Rusakova, I.S. Murashov, A.A. Dokuchaeva, A.V. Bogachev-Prokophiev
目的:通过6个月的随访,评价经二氧氧处理的牛颈静脉导管在大型动物中的性能和短期容量。方法:将13根经二氧氧处理的牛颈静脉导管植入幼猪肺动脉。随访期间,采用经食管超声心动图检测移植物功能。6个月时取出动物,对外植导管进行组织学评估。结果:所有导管均成功植入,无手术并发症。所有的动物在随访期间都存活了下来。随访结束时,5只动物导管压力梯度增加,其中1例导管与原生肺动脉不匹配,2例远端狭窄,2例心内膜炎。随访期间没有观察到瓣膜返流或导管血栓的明显增加。在无功能障碍的导管中,管壁和小叶结构完整。薄纤维组织覆盖导管内壁,表面完全内皮化。导管壁或小叶未见退变、钙化或炎症细胞征象。在两条远端狭窄的导管中观察到新生内膜增生而无钙沉积。外膜可见由多核巨噬细胞、淋巴细胞和组织细胞组成的炎性细胞。中膜、内膜未见炎性细胞,小叶未见改变。结论:二氧氧处理的牛颈静脉表现良好,内皮化良好,血栓形成倾向低,管壁和小叶钙积累倾向低。2022年10月31日收到。2022年11月25日修订。接受日期为2022年11月28日。基金资助:本研究由俄罗斯科学基金资助(批准号:22-25-20102)。利益冲突:作者声明无利益冲突。作者贡献。概念与研究设计:Nichay, I.Yu。数据收集与分析:N.R. Nichay, yu yu。库利亚宾,I.S. Zykov, E.V. Boyarkin, O.Yu。Malakhova, E.V.库兹涅佐娃,T.P. Timchenko, Ya.L。统计分析:N.R. Nichay, I.Yu。文章起草:N.R. Nichay, I.Yu。Zhuravleva Yu.Yu。库利亚宾,I.S. Zykov, E.V. Boyarkin, O.Yu。Malakhova, T.P. Timchenko, Ya.L。本文的修正:N.R. Nichay, I.Yu。Zhuravleva Yu.Yu。库利亚宾,A.A. Dokuchaeva, A.V. bogachev - prokophiev最终批准出版版本:N.R. Nichay, i.u yu。Zhuravleva Yu.Yu。库利亚宾,I.S. Zykov, E.V. Boyarkin, O.Yu。Malakhova, E.V.库兹涅佐娃,T.P. Timchenko, Ya.L。Rusakova, I.S. Murashov, A.A. Dokuchaeva, A.V. Bogachev-Prokophiev
{"title":"Diepoxy-treated bovine jugular vein conduit for pulmonary artery replacement","authors":"N. R. Nichay, I. Zhuravleva, Y. Kulyabin, I. Zykov, E. V. Boyarkin, O. Malakhova, E. V. Kuznetsova, T. Timchenko, Y. Rusakova, I. Murashov, A. Dokuchaeva, A. Bogachev-Prokophiev","doi":"10.21688/1681-3472-2022-4-19-32","DOIUrl":"https://doi.org/10.21688/1681-3472-2022-4-19-32","url":null,"abstract":"Objective: To evaluate the performance and short-term capacity of the diepoxy-treated bovine jugular vein conduit in large animals during 6-month follow-up.Methods: Thirteen diepoxy-treated bovine jugular vein conduits were implanted into the pulmonary artery of young mini-pigs. During the follow-up, graft function was tested using transesophageal echocardiography. The animals were withdrawn at 6 months, and the explanted conduits were assessed histologically.Results: All the conduits were successfully implanted without any surgical complications. All the animals survived throughout the follow-up. By the end of the follow-up period, the pressure gradient increased on five animals’ conduits including one case of mismatch between the conduit and the native pulmonary artery, two cases of distal stenosis, and two case of endocarditis. No significant increase in valve regurgitation or conduit thrombosis was observed during the follow-up. In conduits without dysfunction, the structure of the walls and leaflets was intact. A thin fibrous tissue covered the conduit inner wall with complete surface endothelialization. Neither signs of degeneration or calcification nor inflammatory cells were found in the conduit wall or leaflets. Neointima proliferation without calcium deposits was observed in two distally stenosed conduits. Inflammatory cells consisting of multinucleated macrophages, lymphocytes, and histiocytes were found in the adventitia. There were no inflammatory cells in the media or intima, and the leaflets showed no changes.Conclusion: Diepoxy-treated bovine jugular vein demonstrated acceptable performance, good endothelialization, and low tendency to thrombosis and calcium accumulation in the wall and leaflets.\u0000Received 31 October 2022. Revised 25 November 2022. Accepted 28 November 2022.\u0000Funding: The study was supported by Russian Science Foundation (grant No. 22-25-20102).\u0000Conflict of interest: The authors declare no conflict of interest.\u0000Contribution of the authorsConception and study design: N.R. Nichay, I.Yu. Zhuravleva, A.V. Bogachev-ProkophievData collection and analysis: N.R. Nichay, Yu.Yu. Kulyabin, I.S. Zykov, E.V. Boyarkin, O.Yu. Malakhova, E.V. Kuznetsova, T.P. Timchenko, Ya.L. Rusakova, I.S. Murashov, A.A. DokuchaevaStatistical analysis: N.R. Nichay, I.Yu. ZhuravlevaDrafting the article: N.R. Nichay, I.Yu. Zhuravleva, Yu.Yu. Kulyabin, I.S. Zykov, E.V. Boyarkin, O.Yu. Malakhova, T.P. Timchenko, Ya.L. Rusakova, I.S. Murashov, A.A. DokuchaevaCritical revision of the article: N.R. Nichay, I.Yu. Zhuravleva, Yu.Yu. Kulyabin, A.A. Dokuchaeva, A.V. Bogachev-ProkophievFinal approval of the version to be published: N.R. Nichay, I.Yu. Zhuravleva, Yu.Yu. Kulyabin, I.S. Zykov, E.V. Boyarkin, O.Yu. Malakhova, E.V. Kuznetsova, T.P. Timchenko, Ya.L. Rusakova, I.S. Murashov, A.A. Dokuchaeva, A.V. Bogachev-Prokophiev","PeriodicalId":19853,"journal":{"name":"Patologiya krovoobrashcheniya i kardiokhirurgiya","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85114679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prediction of the acute heart failure after cardiac valve surgery 心脏瓣膜手术后急性心力衰竭的预测
Q4 Medicine Pub Date : 2022-09-30 DOI: 10.21688/1681-3472-2022-3-64-72
V. P. Govorushkina, A. V. Kolesnichenko, E.A. Shirshova, S. Efremov
Background. Postoperative acute heart failure is a frequent complication in cardiac surgery, prolonging the length of stay in the intensive care unit and the hospital length of stay.Aim. To develop prognostic risk model of the acute heart failure in the early postoperative period.Methods. This prospective cohort observation study included 121 adult patients who underwent cardiac valve surgery with cardiopulmonary bypass. The need for vasopressor and inotropic support on the first postoperative day was chosen as the primary endpoint. Univariable and multivariable analysis of logistic regression were used to evaluate the influence of preoperative and intraoperative risk factors.Results. Univariable analysis showed risk factors of using vasopressor and inotropic support on the first day after surgical intervention: duration of cardiopulmonary bypass (OR 1.02, 95% CI 1.005–1.030, p = 0.005), aortic cross-clamping time (OR 1.02, 95% CI 1.001–1.030, p = 0.006), Logistic EuroSCORE II (OR 1.16, 95% CI 0.90–1.49, p = 0.03) and tricuspid valve surgery (OR 2.59, 95% CI 1.09–6.10, p = 0.03). As a result of multivariable analysis, the final model included aortic cross-clamping time and Logistic EuroSCORE II.Use of vasopressors and inotropes on the first day after surgical intervention was associated with an increase of the following parameters: duration of mechanical ventilation (p = 0.013), length of stay in the intensive care unit (p = 0.001), hospital length of stay (p = 0.003), and total postoperative blood loss (p = 0.005).Conclusion. Aortic cross-clamping time and Logistic EuroSCORE II have an independent predictive value for determining the risk of acute heart failure after cardiac surgery.Received 7 February 2022. Revised 29 March 2022. Accepted 11 April 2022.Funding. The study had no sponsorship.Conflict of interest. Authors declare no conflict of interest.Ethics approval. The local ethics committee of Saint Petersburg State University approved the study (protocol No. 3/2019).Contribution of the authors. The authors contributed equally to this article.
背景。术后急性心力衰竭是心脏外科手术中常见的并发症,它延长了患者在重症监护病房的住院时间。目的:建立急性心力衰竭术后早期预后风险模型。这项前瞻性队列观察研究包括121例接受体外循环心脏瓣膜手术的成年患者。术后第一天对血管加压剂和肌力支持的需求被选为主要终点。采用单变量和多变量logistic回归分析评价术前和术中危险因素的影响。单变量分析显示,在手术干预后第一天使用血管加压剂和肌力支持的危险因素:体外循环时间(OR 1.02, 95% CI 1.005-1.030, p = 0.005)、主动脉交叉夹持时间(OR 1.02, 95% CI 1.001-1.030, p = 0.006)、Logistic EuroSCORE II (OR 1.16, 95% CI 0.90-1.49, p = 0.03)和三尖瓣手术(OR 2.59, 95% CI 1.09-6.10, p = 0.03)。通过多变量分析,最终模型包括主动脉交叉夹持时间和Logistic EuroSCORE II。手术干预后第一天使用血管加压药和肌力药物与以下参数增加相关:机械通气时间(p = 0.013)、重症监护病房住院时间(p = 0.001)、住院时间(p = 0.003)和术后总出血量(p = 0.005)。主动脉交叉夹持时间和Logistic EuroSCORE II对确定心脏手术后急性心力衰竭的风险具有独立的预测价值。2022年2月7日收到。2022年3月29日修订。于2022年4月11日接受。这项研究没有赞助。利益冲突。作者声明无利益冲突。伦理批准。圣彼得堡国立大学当地伦理委员会批准了该研究(第3/2019号议定书)。作者的贡献。作者对这篇文章贡献均等。
{"title":"Prediction of the acute heart failure after cardiac valve surgery","authors":"V. P. Govorushkina, A. V. Kolesnichenko, E.A. Shirshova, S. Efremov","doi":"10.21688/1681-3472-2022-3-64-72","DOIUrl":"https://doi.org/10.21688/1681-3472-2022-3-64-72","url":null,"abstract":"Background. Postoperative acute heart failure is a frequent complication in cardiac surgery, prolonging the length of stay in the intensive care unit and the hospital length of stay.Aim. To develop prognostic risk model of the acute heart failure in the early postoperative period.Methods. This prospective cohort observation study included 121 adult patients who underwent cardiac valve surgery with cardiopulmonary bypass. The need for vasopressor and inotropic support on the first postoperative day was chosen as the primary endpoint. Univariable and multivariable analysis of logistic regression were used to evaluate the influence of preoperative and intraoperative risk factors.Results. Univariable analysis showed risk factors of using vasopressor and inotropic support on the first day after surgical intervention: duration of cardiopulmonary bypass (OR 1.02, 95% CI 1.005–1.030, p = 0.005), aortic cross-clamping time (OR 1.02, 95% CI 1.001–1.030, p = 0.006), Logistic EuroSCORE II (OR 1.16, 95% CI 0.90–1.49, p = 0.03) and tricuspid valve surgery (OR 2.59, 95% CI 1.09–6.10, p = 0.03). As a result of multivariable analysis, the final model included aortic cross-clamping time and Logistic EuroSCORE II.Use of vasopressors and inotropes on the first day after surgical intervention was associated with an increase of the following parameters: duration of mechanical ventilation (p = 0.013), length of stay in the intensive care unit (p = 0.001), hospital length of stay (p = 0.003), and total postoperative blood loss (p = 0.005).Conclusion. Aortic cross-clamping time and Logistic EuroSCORE II have an independent predictive value for determining the risk of acute heart failure after cardiac surgery.\u0000Received 7 February 2022. Revised 29 March 2022. Accepted 11 April 2022.\u0000Funding. The study had no sponsorship.\u0000Conflict of interest. Authors declare no conflict of interest.\u0000Ethics approval. The local ethics committee of Saint Petersburg State University approved the study (protocol No. 3/2019).\u0000Contribution of the authors. The authors contributed equally to this article.","PeriodicalId":19853,"journal":{"name":"Patologiya krovoobrashcheniya i kardiokhirurgiya","volume":"346 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79663330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Valve-sparing aortic root replacement in patients with Marfan syndrome: a systematic review 马凡氏综合征患者保留瓣膜的主动脉根置换术:一项系统综述
Q4 Medicine Pub Date : 2022-09-30 DOI: 10.21688/1681-3472-2022-3-21-30
R. Komarov, A.U. Normuradov, R. Isaev, M. Soborov, A.I. Ropova, V.D. Reiter
Aim. To analyze the literature about the results of valve-sparing operations in aortic root surgery in patients with Marfan syndrome. Methods. A comprehensive search included four databases: Pubmed, Embase, Cochrane Library, and Web of Science. Articles for analysis were selected according to the methods presented in the PRISMA 2020 guidelines. Results. The final systematic review included 19 studies and 4 meta-analyses. The findings showed that 30-day and hospital mortality rates did not exceed 2.08%. The incidence of thromboembolism over a 15-year period was 4.1 ± 2.0%. The mean rate of infective endocarditis was 0.25%. Freedom from severe aortic insufficiency 8 years after surgery was 95.2 ± 3.3%. Freedom from reoperation at 8 and 10 years was 97%. Long-term mortality was ≤ 10.57%. The 5-, 10-year survival rates were 95.4 and 84.2% respectively.Conclusion. Valve-sparing operations are more beneficial than valved conduits in patients with Marfan syndrome in the short and long-term periods. Thromboembolism, endocarditis, and bleeding were significantly more common in patients with valved conduits in the long-term period.Received 7 February 2022. Revised 16 May 2022. Accepted 18 May 2022.Funding: The study did not have sponsorship.Conflict of interest: Authors declare no conflict of interest.Contribution of the authorsConception and study design: A.U. Normuradov, R.M. lsaev, M.A. Soborov, A.I. Ropova, V.D. ReiterDrafting the article: A.U. Normuradov, R.M. lsaev, A.I. Ropova, V.D. ReiterCritical revision of the article: A.U. Normuradov, R.M. lsaevFinal approval of the version to be published: R.N. Komarov, A.U. Normuradov, R.M. Isaev, M.A. Soborov, A.I. Ropova, V.D. Reiter
的目标。目的:分析马凡氏综合征主动脉根部手术中保留瓣的相关文献。方法。全面搜索包括四个数据库:Pubmed, Embase, Cochrane Library和Web of Science。根据PRISMA 2020指南中提出的方法选择分析文章。结果。最终的系统综述包括19项研究和4项荟萃分析。结果表明,30天死亡率和住院死亡率均不超过2.08%。15年间血栓栓塞的发生率为4.1±2.0%。感染性心内膜炎的平均发生率为0.25%。术后8年严重主动脉不全发生率为95.2±3.3%。8年和10年的再手术成功率为97%。长期死亡率≤10.57%。5年、10年生存率分别为95.4和84.2%。在马凡氏综合征患者的短期和长期内,保留瓣膜手术比有瓣膜导管手术更有益。血栓栓塞、心内膜炎和出血在长期瓣膜置换术患者中更为常见。2022年2月7日收到。2022年5月16日修订。2022年5月18日接受。经费来源:本研究未获得赞助。利益冲突:作者声明无利益冲突。作者贡献概念和研究设计:A.U. Normuradov, R.M. lsaev, M.A. Soborov, A.I. Ropova, V.D.重申起草文章:A.U. Normuradov, R.M. lsaev, A.I. Ropova, V.D.重申文章的关键修改:A.U. Normuradov, R.M. lsaev最终批准发表的版本:R.N. Komarov, A.U. Normuradov, R.M. Isaev, M.A. Soborov, A.I. Ropova, V.D. Reiter
{"title":"Valve-sparing aortic root replacement in patients with Marfan syndrome: a systematic review","authors":"R. Komarov, A.U. Normuradov, R. Isaev, M. Soborov, A.I. Ropova, V.D. Reiter","doi":"10.21688/1681-3472-2022-3-21-30","DOIUrl":"https://doi.org/10.21688/1681-3472-2022-3-21-30","url":null,"abstract":"Aim. To analyze the literature about the results of valve-sparing operations in aortic root surgery in patients with Marfan syndrome. Methods. A comprehensive search included four databases: Pubmed, Embase, Cochrane Library, and Web of Science. Articles for analysis were selected according to the methods presented in the PRISMA 2020 guidelines. Results. The final systematic review included 19 studies and 4 meta-analyses. The findings showed that 30-day and hospital mortality rates did not exceed 2.08%. The incidence of thromboembolism over a 15-year period was 4.1 ± 2.0%. The mean rate of infective endocarditis was 0.25%. Freedom from severe aortic insufficiency 8 years after surgery was 95.2 ± 3.3%. Freedom from reoperation at 8 and 10 years was 97%. Long-term mortality was ≤ 10.57%. The 5-, 10-year survival rates were 95.4 and 84.2% respectively.Conclusion. Valve-sparing operations are more beneficial than valved conduits in patients with Marfan syndrome in the short and long-term periods. Thromboembolism, endocarditis, and bleeding were significantly more common in patients with valved conduits in the long-term period.\u0000Received 7 February 2022. Revised 16 May 2022. Accepted 18 May 2022.\u0000Funding: The study did not have sponsorship.\u0000Conflict of interest: Authors declare no conflict of interest.\u0000Contribution of the authorsConception and study design: A.U. Normuradov, R.M. lsaev, M.A. Soborov, A.I. Ropova, V.D. ReiterDrafting the article: A.U. Normuradov, R.M. lsaev, A.I. Ropova, V.D. ReiterCritical revision of the article: A.U. Normuradov, R.M. lsaevFinal approval of the version to be published: R.N. Komarov, A.U. Normuradov, R.M. Isaev, M.A. Soborov, A.I. Ropova, V.D. Reiter","PeriodicalId":19853,"journal":{"name":"Patologiya krovoobrashcheniya i kardiokhirurgiya","volume":"58 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83482956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Permanent pacemaker implantation after transcatheter self-expanding aortic valve replacement: data from a single-center registry 经导管自我扩张主动脉瓣置换术后永久起搏器植入:来自单中心登记的数据
Q4 Medicine Pub Date : 2022-09-30 DOI: 10.21688/1681-3472-2022-3-50-63
A. A. Baranov, O. Krestyaninov, D. Khelimskii, A. Badoyan, R. Ibragimov, A. Gorgulko, S. Manukyan, Sh.Sh. Zajnobidinov
Background. Transcatheter aortic valve replacement is a safe and effective procedure in patients with severe aortic stenosis who are at high surgical risk. One of the most commonly diagnosed complications after transcatheter aortic valve replacement is postoperative complete heart block, requiring in most cases the permanent pacemaker implantation.Aim. The study aims to identify independent prognostic factors of permanent pacemaker implantation after transcatheter aortic valve replacement.Methods. This retrospective study included 336 patients who underwent transcatheter self-expanding aortic valve replacement between 2015 and 2021. 28 patients (8.3%) after procedure required the permanent pacemaker implantation. Patients with a previously implanted permanent pacemaker, surgical aortic valve replacement, transcatheter aortic valve replacement in history and patients after conversion of endovascular intervention to surgical replacement were excluded from the study.Results. The mean age of patients was 75.4 ± 7.4 years. Diabetes mellitus (50.0 versus 28.6%, p = 0.03), baseline right bundle-branch block (32.1 versus 3.9%, p < 0.05), and smaller length of the interventricular membranous septum (5.5 ± 2.2 and 6.9 ± 1.8 mm, p < 0.05) were more common in the permanent pacemaker implantation patient group. The groups were comparable in terms of other clinical, demographic and instrumental characteristics. There were no statistically significant differences between the groups in major procedural complications. Independent prognostic factors of permanent pacemaker implantation were baseline complete right bundle-branch block (OR 21.01, 95% CI 5.86–75.42, p < 0,001), mean transcatheter aortic valve implantation depth below the aortic annulus (OR 1.42, 95% CI 1.16–1.74, p = 0.001) and the length of the interventricular membranous septum (OR 0.7, 95% CI 0.50–0.95, p = 0.02).Conclusion. The frequency permanent pacemaker implantation after transcatheter aortic valve replacement procedure depends on some initial clinical factors, procedural aspects, and postoperative conduction disorders. In this registry, independent prognostic factors of a permanent pacemaker implantation were the baseline complete right bundle-branch block, mean transcatheter aortic valve implantationdepth and the length of the interventricular membranous septum.Received 19 March 2022. Revised 18 April 2022. Accepted 19 April 2022.Funding: The study did not have sponsorship.Conflict of interest: Authors declare no conflict of interest.Contribution of the authorsConception and study design: A.A. Baranov, O.V. Krestyaninov, D.A. Khelimskii, A.G. Badoian, R.U. Ibragimov, A.P. Gorgulko, S.N. Manukian, Sh.Sh. ZaynobidinovData collection and analysis: A.A. Baranov, O.V. Krestyaninov, D.A. Khelimskii, A.G. BadoianStatistical analysis: A.A. Baranov, A.G. Badoian, D.A. KhelimskiiDrafting the article: A.A. Baranov, O.V. Krestyaninov, D.A. Khelimskii, A.G. Badoian, R.U. Ibragimov, A.P. Gorgulko, S.N
背景。经导管主动脉瓣置换术是一种安全有效的手术方法,适用于手术风险高的严重主动脉瓣狭窄患者。经导管主动脉瓣置换术后最常见的并发症之一是术后完全性心脏传导阻滞,在大多数情况下需要植入永久性起搏器。本研究旨在确定经导管主动脉瓣置换术后永久性起搏器植入的独立预后因素。这项回顾性研究包括336名在2015年至2021年间接受经导管自我扩张主动脉瓣置换术的患者。28例(8.3%)患者术后需要植入永久性起搏器。既往植入永久性起搏器、手术主动脉瓣置换术、经导管主动脉瓣置换术的患者以及血管内介入治疗转为手术置换术的患者均被排除在研究之外。患者平均年龄75.4±7.4岁。糖尿病(50.0比28.6%,p = 0.03)、基线右束支阻滞(32.1比3.9%,p < 0.05)和较小的室间膜间隔长度(5.5±2.2和6.9±1.8 mm, p < 0.05)在永久性起搏器植入患者组中更为常见。两组在其他临床、人口学和工具特征方面具有可比性。两组间主要手术并发症发生率无统计学差异。永久起搏器植入的独立预后因素为基线完全右束支阻滞(OR 21.01, 95% CI 5.86-75.42, p < 0.001),经导管主动脉瓣植入平均深度低于主动脉环(OR 1.42, 95% CI 1.16-1.74, p = 0.001)和室间隔膜长度(OR 0.7, 95% CI 0.50-0.95, p = 0.02)。经导管主动脉瓣置换术后永久起搏器植入的频率取决于一些初始临床因素、操作方面和术后传导障碍。在本研究中,永久性起搏器植入的独立预后因素是基线完全右束支阻滞、经导管主动脉瓣植入的平均深度和室间隔膜的长度。2022年3月19日收。2022年4月18日修订。接受于2022年4月19日。经费来源:本研究未获得赞助。利益冲突:作者声明无利益冲突。作者贡献。研究构思与设计:A.A. Baranov, O.V. Krestyaninov, D.A. Khelimskii, A.G. Badoian, R.U. Ibragimov, A.P. Gorgulko, S.N. Manukian, Sh.Sh。数据收集与分析:A.A. Baranov, O.V. Krestyaninov, D.A. Khelimskii, A.G. Badoian统计分析:A.A. Baranov, A.G. badoaninov, D.A. Khelimskii, A.G. Badoian, R.U. Ibragimov, A.P. Gorgulko, S.N. Manukian, Sh.Sh。本文关键修订:A.A. Baranov, O.V. Krestyaninov, D.A. Khelimskii, A.G. Badoian, R.U. Ibragimov, A.P. Gorgulko, S.N. Manukian, Sh.Sh。最终批准出版的版本:A.A. Baranov, O.V. Krestyaninov, D.A. Khelimskii, A.G. Badoian, R.U. Ibragimov, A.P. Gorgulko, S.N. Manukian, Sh.Sh。Zaynobidinov
{"title":"Permanent pacemaker implantation after transcatheter self-expanding aortic valve replacement: data from a single-center registry","authors":"A. A. Baranov, O. Krestyaninov, D. Khelimskii, A. Badoyan, R. Ibragimov, A. Gorgulko, S. Manukyan, Sh.Sh. Zajnobidinov","doi":"10.21688/1681-3472-2022-3-50-63","DOIUrl":"https://doi.org/10.21688/1681-3472-2022-3-50-63","url":null,"abstract":"Background. Transcatheter aortic valve replacement is a safe and effective procedure in patients with severe aortic stenosis who are at high surgical risk. One of the most commonly diagnosed complications after transcatheter aortic valve replacement is postoperative complete heart block, requiring in most cases the permanent pacemaker implantation.Aim. The study aims to identify independent prognostic factors of permanent pacemaker implantation after transcatheter aortic valve replacement.Methods. This retrospective study included 336 patients who underwent transcatheter self-expanding aortic valve replacement between 2015 and 2021. 28 patients (8.3%) after procedure required the permanent pacemaker implantation. Patients with a previously implanted permanent pacemaker, surgical aortic valve replacement, transcatheter aortic valve replacement in history and patients after conversion of endovascular intervention to surgical replacement were excluded from the study.Results. The mean age of patients was 75.4 ± 7.4 years. Diabetes mellitus (50.0 versus 28.6%, p = 0.03), baseline right bundle-branch block (32.1 versus 3.9%, p < 0.05), and smaller length of the interventricular membranous septum (5.5 ± 2.2 and 6.9 ± 1.8 mm, p < 0.05) were more common in the permanent pacemaker implantation patient group. The groups were comparable in terms of other clinical, demographic and instrumental characteristics. There were no statistically significant differences between the groups in major procedural complications. Independent prognostic factors of permanent pacemaker implantation were baseline complete right bundle-branch block (OR 21.01, 95% CI 5.86–75.42, p < 0,001), mean transcatheter aortic valve implantation depth below the aortic annulus (OR 1.42, 95% CI 1.16–1.74, p = 0.001) and the length of the interventricular membranous septum (OR 0.7, 95% CI 0.50–0.95, p = 0.02).Conclusion. The frequency permanent pacemaker implantation after transcatheter aortic valve replacement procedure depends on some initial clinical factors, procedural aspects, and postoperative conduction disorders. In this registry, independent prognostic factors of a permanent pacemaker implantation were the baseline complete right bundle-branch block, mean transcatheter aortic valve implantationdepth and the length of the interventricular membranous septum.\u0000Received 19 March 2022. Revised 18 April 2022. Accepted 19 April 2022.\u0000Funding: The study did not have sponsorship.\u0000Conflict of interest: Authors declare no conflict of interest.\u0000Contribution of the authorsConception and study design: A.A. Baranov, O.V. Krestyaninov, D.A. Khelimskii, A.G. Badoian, R.U. Ibragimov, A.P. Gorgulko, S.N. Manukian, Sh.Sh. ZaynobidinovData collection and analysis: A.A. Baranov, O.V. Krestyaninov, D.A. Khelimskii, A.G. BadoianStatistical analysis: A.A. Baranov, A.G. Badoian, D.A. KhelimskiiDrafting the article: A.A. Baranov, O.V. Krestyaninov, D.A. Khelimskii, A.G. Badoian, R.U. Ibragimov, A.P. Gorgulko, S.N","PeriodicalId":19853,"journal":{"name":"Patologiya krovoobrashcheniya i kardiokhirurgiya","volume":"121 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78437005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anthropo-morphometric patterns of design and proportionality of the aortic valve leaflets in light of reconstructive surgery 主动脉瓣重建手术中设计和比例的人类形态计量学模式
Q4 Medicine Pub Date : 2022-09-30 DOI: 10.21688/1681-3472-2022-3-73-84
S. N. Odinokova, R. Komarov, V. Nikolenko, L. Severgina, V. V. Studennikova, R. Belkharoeva
Background. As long as the design of leaflets is crucial for aortic valve replacement, inaccurate reconstruction can result in failure or stenosis postoperatively.Aim. To analyze average parameters of normal valve leaflets and to assess the correlation between various parameters of a normal aortic valve and personal morphometrics. Methods. The morphometrics of the aortic root were assessed on 54 specimens of the adult heart without any valvular abnormality. We measured following parameters: circumference of the ventriculo-aortic junction and the sino-tubular junction; inter-commissural distance, length of free margin, length of cusp attachment, and height for right coronary, non-coronary, and left coronary aortic leaflets. Results. Based on the average values, the left coronary leaflet is distinguished by the smallest dimensions of the length of free margin and length of cusp attachment. The height of the left coronary leaflet is maximum as compared to the right coronary and non-coronary leaflets, but these differences are minimal (up to 0.2 mm), where the left coronary leaflet is the smallest. Statistically, no significant intergroup difference was found. For all valve sizes, p > 0.05 (inter-commissural distance p = 0.083, length of free margin p = 0.331, length of cusp attachment p = 0.056, height of leaflet p = 0.518). Significant correlations were found between all aortic valve leaflet sizes and the ventriculo-aortic junction and the sino-tubular junction. A weaker correlation was found between all leaflets sizes and the body height.Conclusion. The findings can be used to optimize the leaflet reconstruction and improve the aortic valve function.Received 9 September 2020. Revised 10 September 2021. Accepted 29 June 2022.Funding: The study did not have sponsorship.Conflict of interest: Authors declare no conflict of interest.Contribution of the authorsConception and study design: R.N. Komarov, V.N. Nikolenko, S.N. OdinokovaData collection and analysis: S.N. Odinokova, V.V. Studennikova, L.O. SeverginaStatistical analysis: S.N. OdinokovaDrafting the article: S.N. Odinokova, R.Kh. BelkharoevaCritical revision of the article: R.N. Komarov, V.N. NikolenkoFinal approval of the version to be published: S.N. Odinokova, R.N. Komarov, V.N. Nikolenko, L.O. Severgina, V.V. Studennikova, R.Kh. Belkharoeva
背景。只要小叶的设计是主动脉瓣置换术的关键,不准确的重建可能导致术后失败或狭窄。分析正常主动脉瓣叶的平均参数,评价正常主动脉瓣各参数与个人形态计量学的相关性。方法。我们对54例无瓣膜异常的成人心脏进行了主动脉根形态测量。我们测量了以下参数:心室-主动脉交界处和管状交界处的周长;左、右冠状动脉、非冠状动脉和左冠状动脉主动脉小叶的离心距离、游离缘长度、尖端附着体长度和高度。结果。根据平均值,左冠状动脉小叶以自由缘长度和尖附着长度的最小尺寸来区分。与右冠状动脉和非冠状动脉小叶相比,左冠状动脉小叶的高度最大,但这些差异很小(可达0.2毫米),其中左冠状动脉小叶最小。组间差异无统计学意义。各瓣膜通径p > 0.05(节间距离p = 0.083,自由缘长度p = 0.331,瓣尖附着长度p = 0.056,小叶高度p = 0.518)。所有主动脉瓣小叶大小与心室-主动脉交界处和肾管交界处均有显著相关性。小叶大小与体高的相关性较弱。该结果可用于优化小叶重建,改善主动脉瓣功能。2020年9月9日收。2021年9月10日修订。接受2022年6月29日。经费来源:本研究未获得赞助。利益冲突:作者声明无利益冲突。作者贡献。研究构思与设计:R.N. Komarov, V.N. Nikolenko, S.N. Odinokova收集与分析:S.N. Odinokova, V.V. Studennikova, L.O. severginn统计分析:S.N. Odinokova文章撰写:S.N. Odinokova, R.Kh。文章批改:R.N.科马罗夫,V.N.尼古连科最终审定版:S.N.奥迪诺科娃,R.N.科马罗夫,V.N.尼古连科,L.O.塞维吉纳,V.V.斯图坚尼科娃,R.Kh。Belkharoeva
{"title":"Anthropo-morphometric patterns of design and proportionality of the aortic valve leaflets in light of reconstructive surgery","authors":"S. N. Odinokova, R. Komarov, V. Nikolenko, L. Severgina, V. V. Studennikova, R. Belkharoeva","doi":"10.21688/1681-3472-2022-3-73-84","DOIUrl":"https://doi.org/10.21688/1681-3472-2022-3-73-84","url":null,"abstract":"Background. As long as the design of leaflets is crucial for aortic valve replacement, inaccurate reconstruction can result in failure or stenosis postoperatively.Aim. To analyze average parameters of normal valve leaflets and to assess the correlation between various parameters of a normal aortic valve and personal morphometrics. Methods. The morphometrics of the aortic root were assessed on 54 specimens of the adult heart without any valvular abnormality. We measured following parameters: circumference of the ventriculo-aortic junction and the sino-tubular junction; inter-commissural distance, length of free margin, length of cusp attachment, and height for right coronary, non-coronary, and left coronary aortic leaflets. Results. Based on the average values, the left coronary leaflet is distinguished by the smallest dimensions of the length of free margin and length of cusp attachment. The height of the left coronary leaflet is maximum as compared to the right coronary and non-coronary leaflets, but these differences are minimal (up to 0.2 mm), where the left coronary leaflet is the smallest. Statistically, no significant intergroup difference was found. For all valve sizes, p > 0.05 (inter-commissural distance p = 0.083, length of free margin p = 0.331, length of cusp attachment p = 0.056, height of leaflet p = 0.518). Significant correlations were found between all aortic valve leaflet sizes and the ventriculo-aortic junction and the sino-tubular junction. A weaker correlation was found between all leaflets sizes and the body height.Conclusion. The findings can be used to optimize the leaflet reconstruction and improve the aortic valve function.\u0000Received 9 September 2020. Revised 10 September 2021. Accepted 29 June 2022.\u0000Funding: The study did not have sponsorship.\u0000Conflict of interest: Authors declare no conflict of interest.\u0000Contribution of the authorsConception and study design: R.N. Komarov, V.N. Nikolenko, S.N. OdinokovaData collection and analysis: S.N. Odinokova, V.V. Studennikova, L.O. SeverginaStatistical analysis: S.N. OdinokovaDrafting the article: S.N. Odinokova, R.Kh. BelkharoevaCritical revision of the article: R.N. Komarov, V.N. NikolenkoFinal approval of the version to be published: S.N. Odinokova, R.N. Komarov, V.N. Nikolenko, L.O. Severgina, V.V. Studennikova, R.Kh. Belkharoeva","PeriodicalId":19853,"journal":{"name":"Patologiya krovoobrashcheniya i kardiokhirurgiya","volume":"99 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78367955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
State-of-the-art surgical approaches in minimally invasive aortic valve surgery 最先进的微创主动脉瓣手术入路
Q4 Medicine Pub Date : 2022-09-30 DOI: 10.21688/1681-3472-2022-3-31-40
R. Komarov, O. O. Ognev, A. Ismailbaev, S. Cherniavskii, A. N. Dzyundzya, M. Lenkovets
Over the past 30 years, minimally invasive cardiac surgery has progressed from single case reports of operations via thoracotomy and various procedures of partial sternotomy to routine use of mini-accesses as well as fully thoracoscopic and robotic techniques. It is aortic valve surgery that implemented minimally invasive technologies most widely. The objective of this systematic review is to present state-of-the-art approaches to minimally invasive aortic valve surgery including patient selection criteria as well as evolution and state-of-the-art of the main surgical approaches. The search strategy covered international databases, such as PubMed, Scopus, Embase, and Web of Science. We used following queries: ‘minimally invasive surgery of the aortic valve’, ‘alternative surgical approaches in aortic valve surgery’, ‘minimally invasive autologous pericardium neocuspidization’. Selection of patients for minimally invasive aortic interventions should consider both the anatomy of the mediastinum and the aortic root as well as cardiac and other comorbidities. Minimally invasive approaches in aortic valve surgery include thoracotomy, partial sternotomy, and endoscopic techniques. Of particular interest is minimally invasive neocuspidization with autologous pericardium. Partial sternotomies are the most routinely used approaches in aortic valve surgery. Their cumulative outcomes allow to compare their efficacy and safety with those of classic sternotomy access within large meta-analyses. Minimally invasive autopericardial neocuspidization and endoscopic interventions on the aortic valve require further surgical experience and clinical outcomes.Received 17 January 2022. Revised 6 April 2022. Accepted 8 April 2022.Funding: The study did not have sponsorship.Conflict of interest: Authors declare no conflict of interest.Contribution of the authorsConception and study design: R.N. Komarov, S.V. Cherniavskii, A.N. DzyundzyaDrafting the article: O.O. Ognev, M.V. LenkovetsCritical revision of the article: A.M. IsmailbaevFinal approval of the version to be published: R.N. Komarov, O.O. Ognev, A.M. Ismailbaev, S.V. Cherniavskii, A.N. Dzyundzya, M.V. Lenkovets
在过去的30年里,微创心脏手术已经从单个病例报告的开胸手术和各种胸骨部分切开手术发展到常规使用小通道、全胸腔镜和机器人技术。微创技术应用最广泛的是主动脉瓣手术。本系统综述的目的是介绍微创主动脉瓣手术的最新方法,包括患者选择标准以及主要手术方法的发展和最新进展。搜索策略覆盖了国际数据库,如PubMed、Scopus、Embase和Web of Science。我们使用了以下查询:“主动脉瓣的微创手术”,“主动脉瓣手术的替代手术入路”,“微创自体心包新瓣化”。选择微创主动脉介入治疗的患者应考虑纵隔和主动脉根的解剖结构以及心脏和其他合并症。主动脉瓣手术的微创入路包括开胸、部分胸骨切开术和内窥镜技术。特别值得关注的是自体心包微创新冠术。部分胸骨切开术是主动脉瓣手术中最常用的入路。其累积结果允许在大型荟萃分析中将其与经典胸骨切开术的疗效和安全性进行比较。微创自心包主动脉瓣置换术和内窥镜介入主动脉瓣需要进一步的手术经验和临床结果。2022年1月17日收到。2022年4月6日修订。接受于2022年4月8日。经费来源:本研究未获得赞助。利益冲突:作者声明无利益冲突。作者贡献。研究构思与设计:R.N. Komarov, S.V. Cherniavskii, A.N. dzyundz。论文提稿:O.O. Ognev, M.V. lenkovismailbaev即将出版的版本的最终批准:R.N. Komarov, O.O. Ognev, A.M.Ismailbaev, S.V. Cherniavskii, A.N. Dzyundzya, M.V. Lenkovets
{"title":"State-of-the-art surgical approaches in minimally invasive aortic valve surgery","authors":"R. Komarov, O. O. Ognev, A. Ismailbaev, S. Cherniavskii, A. N. Dzyundzya, M. Lenkovets","doi":"10.21688/1681-3472-2022-3-31-40","DOIUrl":"https://doi.org/10.21688/1681-3472-2022-3-31-40","url":null,"abstract":"Over the past 30 years, minimally invasive cardiac surgery has progressed from single case reports of operations via thoracotomy and various procedures of partial sternotomy to routine use of mini-accesses as well as fully thoracoscopic and robotic techniques. It is aortic valve surgery that implemented minimally invasive technologies most widely. The objective of this systematic review is to present state-of-the-art approaches to minimally invasive aortic valve surgery including patient selection criteria as well as evolution and state-of-the-art of the main surgical approaches. The search strategy covered international databases, such as PubMed, Scopus, Embase, and Web of Science. We used following queries: ‘minimally invasive surgery of the aortic valve’, ‘alternative surgical approaches in aortic valve surgery’, ‘minimally invasive autologous pericardium neocuspidization’. Selection of patients for minimally invasive aortic interventions should consider both the anatomy of the mediastinum and the aortic root as well as cardiac and other comorbidities. Minimally invasive approaches in aortic valve surgery include thoracotomy, partial sternotomy, and endoscopic techniques. Of particular interest is minimally invasive neocuspidization with autologous pericardium. Partial sternotomies are the most routinely used approaches in aortic valve surgery. Their cumulative outcomes allow to compare their efficacy and safety with those of classic sternotomy access within large meta-analyses. Minimally invasive autopericardial neocuspidization and endoscopic interventions on the aortic valve require further surgical experience and clinical outcomes.\u0000Received 17 January 2022. Revised 6 April 2022. Accepted 8 April 2022.\u0000Funding: The study did not have sponsorship.\u0000Conflict of interest: Authors declare no conflict of interest.\u0000Contribution of the authorsConception and study design: R.N. Komarov, S.V. Cherniavskii, A.N. DzyundzyaDrafting the article: O.O. Ognev, M.V. LenkovetsCritical revision of the article: A.M. IsmailbaevFinal approval of the version to be published: R.N. Komarov, O.O. Ognev, A.M. Ismailbaev, S.V. Cherniavskii, A.N. Dzyundzya, M.V. Lenkovets","PeriodicalId":19853,"journal":{"name":"Patologiya krovoobrashcheniya i kardiokhirurgiya","volume":"37 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90915716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Endovascular treatment of the gluteal artery pseudoaneurysm: a case report 血管内治疗臀动脉假性动脉瘤1例
Q4 Medicine Pub Date : 2022-09-30 DOI: 10.21688/1681-3472-2022-3-103-108
N. Susanin, M. Chernyavskiy, A. Vanyurkin, A. Vlasovets, K.P. Moiseev
False aneurysms, also known as pseudoaneurysms, most commonly occur when the main arteries are injured in various ways. False aneurysms of smaller arteries located in the hard-to-reach areas are less common. These include aneurysms of the gluteal arteries. This disorder presents a serious problem due to both difficulties in diagnosis and in determining the tactics of surgical treatment. This article presents a case of successfully treated pseudoaneurysm of the gluteal artery in an elderly patient with underlying severe comorbidities. A 73-year-old patient was admitted to the clinic of vascular surgery with complaints of discomfort and pulsating sensation in the right gluteal region during exercise. Ultrasound examination and multislice computed tomography revealed a false aneurysm in the branch of the internal iliac artery measuring 57 × 36 × 46 mm, which was an indication for surgical treatment. The endovascular treatment scoped implantation of the occluder in the superior gluteal artery. The perioperative period was uneventful. According to the scheduled postoperative examination, the patient's condition was satisfactory. Of practical and clinical interest is the fact that the treatment of this disorder is a technically complex and time-consuming process. In this case, the endovascular treatment of aneurysm with an occluder resulted in an adequate therapeutic effect in the patient with underlying severe comorbidities and reduced the risk of perioperative complications. The patient returned to a normal life within a short time.Received 12 February 2022. Revised 3 April 2022. Accepted 4 April 2022.Informed consent: The patient’s informed consent to use the records for medical purposes is obtained.Funding: The study did not have sponsorship.Conflict of interest: Authors declare no conflict of interest.Contribution of the authorsLiterature review: K.P. Moiseev, A.A. VlasovetsDrafting the article: N.V. Susanin, A.G. VanyurkinCritical revision of the article: N.V. SusaninSurgical treatment: M.A. Chernyavskiy, N.V. SusaninFinal approval of the version to be published: N.V. Susanin, M.A. Chernyavskiy, A.G. Vanyurkin, A.A. Vlasovets, K.P. Moiseev
假性动脉瘤,也称为假性动脉瘤,最常发生在主动脉以各种方式受伤时。位于难以到达区域的小动脉的假动脉瘤不太常见。包括臀动脉的动脉瘤。由于诊断和确定手术治疗策略的困难,这种疾病提出了一个严重的问题。本文提出一例成功治疗的臀动脉假性动脉瘤在一个老年病人的潜在严重的合并症。病人73岁,因运动时右臀区不适及搏动感而入血管外科门诊。超声及多层螺旋ct示髂内动脉分支假动脉瘤,尺寸为57 × 36 × 46 mm,需手术治疗。血管内治疗的范围是在臀上动脉内植入闭塞器。围手术期平安无事。根据术后安排的检查,患者的情况令人满意。实际和临床的兴趣是,这种疾病的治疗是一个技术上复杂和耗时的过程。在本例中,血管内动脉瘤闭塞治疗对伴有严重合并症的患者产生了足够的治疗效果,并降低了围手术期并发症的风险。病人很快就恢复了正常生活。收到2022年2月12日。2022年4月3日修订。接受于2022年4月4日。知情同意:已取得患者知情同意将病历用于医疗目的。经费来源:本研究未获得赞助。利益冲突:作者声明无利益冲突。作者贡献文献综述:K.P. Moiseev, A.A. vlasovet文章起草:N.V. Susanin, A.G. Vanyurkin文章关键性修改:N.V. susany手术治疗:M.A. Chernyavskiy, N.V. susany最终审定版本:N.V. Susanin, M.A. Chernyavskiy, A.G. Vanyurkin, A.A. Vlasovets, K.P. Moiseev
{"title":"Endovascular treatment of the gluteal artery pseudoaneurysm: a case report","authors":"N. Susanin, M. Chernyavskiy, A. Vanyurkin, A. Vlasovets, K.P. Moiseev","doi":"10.21688/1681-3472-2022-3-103-108","DOIUrl":"https://doi.org/10.21688/1681-3472-2022-3-103-108","url":null,"abstract":"False aneurysms, also known as pseudoaneurysms, most commonly occur when the main arteries are injured in various ways. False aneurysms of smaller arteries located in the hard-to-reach areas are less common. These include aneurysms of the gluteal arteries. This disorder presents a serious problem due to both difficulties in diagnosis and in determining the tactics of surgical treatment. This article presents a case of successfully treated pseudoaneurysm of the gluteal artery in an elderly patient with underlying severe comorbidities. A 73-year-old patient was admitted to the clinic of vascular surgery with complaints of discomfort and pulsating sensation in the right gluteal region during exercise. Ultrasound examination and multislice computed tomography revealed a false aneurysm in the branch of the internal iliac artery measuring 57 × 36 × 46 mm, which was an indication for surgical treatment. The endovascular treatment scoped implantation of the occluder in the superior gluteal artery. The perioperative period was uneventful. According to the scheduled postoperative examination, the patient's condition was satisfactory. Of practical and clinical interest is the fact that the treatment of this disorder is a technically complex and time-consuming process. In this case, the endovascular treatment of aneurysm with an occluder resulted in an adequate therapeutic effect in the patient with underlying severe comorbidities and reduced the risk of perioperative complications. The patient returned to a normal life within a short time.\u0000Received 12 February 2022. Revised 3 April 2022. Accepted 4 April 2022.\u0000Informed consent: The patient’s informed consent to use the records for medical purposes is obtained.\u0000Funding: The study did not have sponsorship.\u0000Conflict of interest: Authors declare no conflict of interest.\u0000Contribution of the authorsLiterature review: K.P. Moiseev, A.A. VlasovetsDrafting the article: N.V. Susanin, A.G. VanyurkinCritical revision of the article: N.V. SusaninSurgical treatment: M.A. Chernyavskiy, N.V. SusaninFinal approval of the version to be published: N.V. Susanin, M.A. Chernyavskiy, A.G. Vanyurkin, A.A. Vlasovets, K.P. Moiseev","PeriodicalId":19853,"journal":{"name":"Patologiya krovoobrashcheniya i kardiokhirurgiya","volume":"99 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77566492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Technical features of a self-expandable prosthetic valve for the treatment of pulmonary valve disease 一种用于治疗肺瓣膜疾病的自膨胀假体瓣膜的技术特点
Q4 Medicine Pub Date : 2022-09-30 DOI: 10.21688/1681-3472-2022-3-85-90
K. Rzaeva, T. Timchenko, I. Zhuravleva, A. Arkhipov, A. Gorbatykh, A. Voitov, N. Nichay, A. Bogachev-Prokophiev, I. Soynov
Background. Balloon-expandable prostheses authorized for transcatheter pulmonary valve replacement in the Russian Federation have a barrel-shaped frame, which requires pre-stenting of a native right ventricular outflow tract or a conduit. This increases procedure duration, complicates implantation technique, and increases operation costs. Aim. To develop a self-expandable pulmonary valve model for transcatheter replacement and prepare it for preclinical trials.Methods. The model of a self-expandable pulmonary valve bioprothesis for transcatheter replacement made of nitinol was developed. The leaflets and the lining of the frame were made of porcine pericardium and assembled manually. Radial force testing was performed; valve loading into the delivery system was also tested.Results. According to the results of the tests, the valve biomaterial and the suture sites were not damaged after compression. In 2022, initial preclinical tests are scheduled to determine viability of the implanted valves at 6 and 12 months after surgery, and the rate of calcification for this observation period is to be assessed as well.Conclusion. By optimizing the design of the support frame, we improved the transcatheter model of the biological valve with satisfactory results at the initial stage of preclinical trials.Received 22 April 2022. Revised 5 May 2022. Accepted 11 May 2022.Funding: This work is supported by a grant of the Russian Science Foundation (project No. 21-75-10041).Conflict of interest: Authors declare no conflict of interest.Contribution of the authorsConception and study design: K.A. Rzaeva, T.P. Timchenko, A.N. Arkhipov, N.R. NichayData collection and analysis: A.V. Voitov, N.R. NichayDrafting the article: K.A. Rzaeva, A.V. GorbatykhCritical revision of the article: I.Yu. Zhuravleva, I.A. Soynov, A.V. Bogachev-ProkophievFinal approval of the version to be published: K.A. Rzaeva, T.P. Timchenko, I.Yu. Zhuravleva, A.N. Arkhipov, A.V. Gorbatykh, A.V. Voitov, N.R. Nichay, A.V. Bogachev-Prokophiev, I.A. Soynov
背景。俄罗斯联邦批准用于经导管肺瓣膜置换术的可膨胀气球假体具有桶形框架,需要预先植入天然右心室流出道或导管。这增加了手术时间,使植入技术复杂化,并增加了手术成本。的目标。目的:建立经导管置换术用自膨胀肺瓣膜模型,为临床前试验做准备。建立了镍钛诺生物假体经导管置换术用自膨胀肺瓣膜模型。小叶和框架的衬里是由猪心包和手工组装。进行径向力测试;并对输送系统的阀负载进行了测试。根据试验结果,瓣膜生物材料和缝合部位在压缩后未受到损伤。2022年,计划进行初步临床前试验,以确定术后6个月和12个月植入瓣膜的活力,并评估这一观察期的钙化率。通过优化支撑架的设计,我们改进了经导管生物瓣膜模型,在临床前试验初期取得了满意的效果。2022年4月22日收到。2022年5月5日修订。2022年5月11日接受。基金资助:本工作由俄罗斯科学基金资助(项目号21-75-10041)。利益冲突:作者声明无利益冲突。作者贡献。研究构思与设计:K.A. Rzaeva, T.P. Timchenko, A.N. Arkhipov, N.R. nichai资料收集与分析:A.V. Voitov, N.R. nichai论文撰写:K.A. Rzaeva, A.V. gorbatyh论文关键修改:i.u yu。朱拉夫列娃,a . a .索伊诺夫,A.V.博加切夫-普罗科菲耶夫最终批准出版的版本:K.A. Rzaeva, T.P. Timchenko, I.Yu。Zhuravleva, A.N. Arkhipov, A.V. Gorbatykh, A.V. Voitov, N.R. Nichay, A.V. Bogachev-Prokophiev, I.A. Soynov
{"title":"Technical features of a self-expandable prosthetic valve for the treatment of pulmonary valve disease","authors":"K. Rzaeva, T. Timchenko, I. Zhuravleva, A. Arkhipov, A. Gorbatykh, A. Voitov, N. Nichay, A. Bogachev-Prokophiev, I. Soynov","doi":"10.21688/1681-3472-2022-3-85-90","DOIUrl":"https://doi.org/10.21688/1681-3472-2022-3-85-90","url":null,"abstract":"Background. Balloon-expandable prostheses authorized for transcatheter pulmonary valve replacement in the Russian Federation have a barrel-shaped frame, which requires pre-stenting of a native right ventricular outflow tract or a conduit. This increases procedure duration, complicates implantation technique, and increases operation costs. Aim. To develop a self-expandable pulmonary valve model for transcatheter replacement and prepare it for preclinical trials.Methods. The model of a self-expandable pulmonary valve bioprothesis for transcatheter replacement made of nitinol was developed. The leaflets and the lining of the frame were made of porcine pericardium and assembled manually. Radial force testing was performed; valve loading into the delivery system was also tested.Results. According to the results of the tests, the valve biomaterial and the suture sites were not damaged after compression. In 2022, initial preclinical tests are scheduled to determine viability of the implanted valves at 6 and 12 months after surgery, and the rate of calcification for this observation period is to be assessed as well.Conclusion. By optimizing the design of the support frame, we improved the transcatheter model of the biological valve with satisfactory results at the initial stage of preclinical trials.\u0000Received 22 April 2022. Revised 5 May 2022. Accepted 11 May 2022.\u0000Funding: This work is supported by a grant of the Russian Science Foundation (project No. 21-75-10041).\u0000Conflict of interest: Authors declare no conflict of interest.\u0000Contribution of the authorsConception and study design: K.A. Rzaeva, T.P. Timchenko, A.N. Arkhipov, N.R. NichayData collection and analysis: A.V. Voitov, N.R. NichayDrafting the article: K.A. Rzaeva, A.V. GorbatykhCritical revision of the article: I.Yu. Zhuravleva, I.A. Soynov, A.V. Bogachev-ProkophievFinal approval of the version to be published: K.A. Rzaeva, T.P. Timchenko, I.Yu. Zhuravleva, A.N. Arkhipov, A.V. Gorbatykh, A.V. Voitov, N.R. Nichay, A.V. Bogachev-Prokophiev, I.A. Soynov","PeriodicalId":19853,"journal":{"name":"Patologiya krovoobrashcheniya i kardiokhirurgiya","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79929738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distal radial access in percutaneous non-coronary interventions 经皮非冠状动脉介入治疗中的远端桡动脉通路
Q4 Medicine Pub Date : 2022-09-30 DOI: 10.21688/1681-3472-2022-3-41-49
A. Korotkikh, A. Babunashvili, A. Kazantsev, E. V. Tarasyuk
Since the inception of interventional cardiology and for decades, the femoral artery has been the only access of choice for coronary angiography and intervention. Over the past 20 years an extensive evidence data accumulated, and most interventional cardiologists around the world have almost completely switched to routine radial access in both elective and emergency procedures, and in the last 5 years, a similar trend has been observed about distal radial access. Non-coronary endovascular interventions go through all the same stages to improve and optimize the approaches, but in a more accelerated way. The aim of this review was to analyze the literature on distal radial access in non-coronary interventions. Currently, according to retrospective studies and single observations, there is a clinical benefit to perform non-cardiac endovascular interventions through distal radial access. However, it is necessary to conduct prospective studies in the context of early, mid-term and long-term outcomes.Received 16 February 2022. Revised 31 March 2022. Accepted 1 April 2022.Funding: The study did not have sponsorship.Conflict of interest: Authors declare no conflict of interest.Contribution of the authors: The authors contributed equally to this article.
自介入心脏病学开始以来,几十年来,股动脉一直是冠状动脉造影和介入治疗的唯一途径。在过去的20年里积累了大量的证据数据,世界上大多数介入心脏病专家几乎完全在选择性和急诊手术中转向常规的桡骨通路,在过去的5年里,桡骨远端通路也出现了类似的趋势。非冠状动脉血管内介入治疗经历了所有相同的阶段,以改进和优化方法,但以更快的方式。本综述的目的是分析非冠状动脉介入治疗中桡动脉远端通路的文献。目前,根据回顾性研究和单一观察,通过桡骨远端通路进行非心脏血管内介入治疗具有临床益处。然而,有必要在早期、中期和长期结果的背景下进行前瞻性研究。2022年2月16日收到。2022年3月31日修订。接受于2022年4月1日。经费来源:本研究未获得赞助。利益冲突:作者声明无利益冲突。作者的贡献:作者对本文的贡献相同。
{"title":"Distal radial access in percutaneous non-coronary interventions","authors":"A. Korotkikh, A. Babunashvili, A. Kazantsev, E. V. Tarasyuk","doi":"10.21688/1681-3472-2022-3-41-49","DOIUrl":"https://doi.org/10.21688/1681-3472-2022-3-41-49","url":null,"abstract":"Since the inception of interventional cardiology and for decades, the femoral artery has been the only access of choice for coronary angiography and intervention. Over the past 20 years an extensive evidence data accumulated, and most interventional cardiologists around the world have almost completely switched to routine radial access in both elective and emergency procedures, and in the last 5 years, a similar trend has been observed about distal radial access. Non-coronary endovascular interventions go through all the same stages to improve and optimize the approaches, but in a more accelerated way. The aim of this review was to analyze the literature on distal radial access in non-coronary interventions. Currently, according to retrospective studies and single observations, there is a clinical benefit to perform non-cardiac endovascular interventions through distal radial access. However, it is necessary to conduct prospective studies in the context of early, mid-term and long-term outcomes.\u0000Received 16 February 2022. Revised 31 March 2022. Accepted 1 April 2022.\u0000Funding: The study did not have sponsorship.\u0000Conflict of interest: Authors declare no conflict of interest.\u0000Contribution of the authors: The authors contributed equally to this article.","PeriodicalId":19853,"journal":{"name":"Patologiya krovoobrashcheniya i kardiokhirurgiya","volume":"179 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75842850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BioBentall procedure and autological materials in aortic root surgery 主动脉根部手术中的生物obentall程序和自体材料
Q4 Medicine Pub Date : 2022-09-30 DOI: 10.21688/1681-3472-2022-3-9-20
R. Komarov, A. Ismailbaev, S. Cherniavskii, A. N. Dzyundzya, A. Danachev, O. O. Ognev, M.V. Lencovets
The BioBentall procedure has many options, but the optimal approach is still not determined. Alternative options for aortic root surgery include Ross procedure and modification of the Bentall – De Bono procedure using autologous pericardium leaflets. This literature review showed topical issues of surgical technique and the results of various modifications of the BioBentall operation, as well as methods of the aortic root repair using autologous materials. The search strategy included the analysis of international (PubMed, Scopus, Embase) and Russian’s databases (Russian Science Citation Index). The BioBentall procedure demonstrates satisfactory early and long-term results comparable to both the classic Bentall – De Bono procedure and valve-sparing techniques. Composite grafts containing frameless bioprostheses seem to be more promising and durable in comparison with stent-grafts, however, given the minimal amount of publications directly comparing these techniques, further study of this hypothesis is necessary. Total xenopericardial conduits have demonstrated higher rates of degradation and are currently not recommended for use, as demonstrated in most foreign studies. Modified Ross procedure shows excellent hemodynamic outcomes in the long-term follow-up, however, the literature data regarding its applicability in a cohort of patients with proximal aortic aneurysms are limited. The combination of the Bentall – De Bono procedure and autopericardial neocuspidization seems to be a promising and cost-effective method, however, this approach requires a clinical assessment, which results have not been yet published.Received 26 February 2022. Revised 20 April 2022. Accepted 21 April 2022.Funding: The study did not have sponsorship.Conflict of interest: Authors declare no conflict of interest.Contribution of the authorsConception and study design: R.N. Komarov, A.M. IsmailbaevDrafting the article: A.N. Dzyundzya, A.O. Danachev, O.O. Ognev, M.V. LencovetsCritical revision of the article: S.V. CherniavskiiFinal approval of the version to be published: R.N. Komarov, A.M. Ismailbaev, S.V. Cherniavskii, A.N. Dzyundzya, A.O. Danachev, O.O. Ognev, M.V. Lencovets
BioBentall手术有许多选择,但最佳方法仍未确定。主动脉根部手术的其他选择包括Ross手术和使用自体心包小叶改良的Bentall - De Bono手术。这篇文献综述显示了外科技术和各种BioBentall手术修改的结果的局部问题,以及使用自体材料修复主动脉根部的方法。检索策略包括对国际数据库(PubMed, Scopus, Embase)和俄罗斯数据库(Russian Science Citation Index)的分析。与传统的Bentall - De Bono手术和保留瓣膜技术相比,BioBentall手术的早期和长期效果都令人满意。与支架移植相比,含有无框生物假体的复合移植物似乎更有希望和耐用,然而,由于直接比较这些技术的出版物很少,因此有必要进一步研究这一假设。国外大多数研究表明,全外心包导管的降解率较高,目前不推荐使用。改良的Ross手术在长期随访中显示出良好的血流动力学结果,然而,关于其在近端动脉瘤患者队列中的适用性的文献数据有限。Bentall - De Bono手术和心包自体新冠术的结合似乎是一种很有前途和成本效益的方法,然而,这种方法需要临床评估,其结果尚未发表。2022年2月26日收到。2022年4月20日修订。接受于2022年4月21日。经费来源:本研究未获得赞助。利益冲突:作者声明无利益冲突。作者贡献。概念与研究设计:R.N. Komarov, A.M.ismailbav文章起草:A.N. Dzyundzya, A.O. Danachev, O.O. Ognev, M.V. lencovev文章批改:S.V. cherniavskiy最终审定版本:R.N. Komarov, A.M.Ismailbaev, S.V. Cherniavskii, A.N. Dzyundzya, A.O. Danachev, O.O. Ognev, M.V. lencovts
{"title":"BioBentall procedure and autological materials in aortic root surgery","authors":"R. Komarov, A. Ismailbaev, S. Cherniavskii, A. N. Dzyundzya, A. Danachev, O. O. Ognev, M.V. Lencovets","doi":"10.21688/1681-3472-2022-3-9-20","DOIUrl":"https://doi.org/10.21688/1681-3472-2022-3-9-20","url":null,"abstract":"The BioBentall procedure has many options, but the optimal approach is still not determined. Alternative options for aortic root surgery include Ross procedure and modification of the Bentall – De Bono procedure using autologous pericardium leaflets. This literature review showed topical issues of surgical technique and the results of various modifications of the BioBentall operation, as well as methods of the aortic root repair using autologous materials. The search strategy included the analysis of international (PubMed, Scopus, Embase) and Russian’s databases (Russian Science Citation Index). The BioBentall procedure demonstrates satisfactory early and long-term results comparable to both the classic Bentall – De Bono procedure and valve-sparing techniques. Composite grafts containing frameless bioprostheses seem to be more promising and durable in comparison with stent-grafts, however, given the minimal amount of publications directly comparing these techniques, further study of this hypothesis is necessary. Total xenopericardial conduits have demonstrated higher rates of degradation and are currently not recommended for use, as demonstrated in most foreign studies. Modified Ross procedure shows excellent hemodynamic outcomes in the long-term follow-up, however, the literature data regarding its applicability in a cohort of patients with proximal aortic aneurysms are limited. The combination of the Bentall – De Bono procedure and autopericardial neocuspidization seems to be a promising and cost-effective method, however, this approach requires a clinical assessment, which results have not been yet published.\u0000Received 26 February 2022. Revised 20 April 2022. Accepted 21 April 2022.\u0000Funding: The study did not have sponsorship.\u0000Conflict of interest: Authors declare no conflict of interest.\u0000Contribution of the authorsConception and study design: R.N. Komarov, A.M. IsmailbaevDrafting the article: A.N. Dzyundzya, A.O. Danachev, O.O. Ognev, M.V. LencovetsCritical revision of the article: S.V. CherniavskiiFinal approval of the version to be published: R.N. Komarov, A.M. Ismailbaev, S.V. Cherniavskii, A.N. Dzyundzya, A.O. Danachev, O.O. Ognev, M.V. Lencovets","PeriodicalId":19853,"journal":{"name":"Patologiya krovoobrashcheniya i kardiokhirurgiya","volume":"25 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77980446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Patologiya krovoobrashcheniya i kardiokhirurgiya
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1